Flosonics Medical

Flosonics Medical is a Canadian medical device company dedicated to developing innovative ultrasound technology. Their flagship product, FloPatch, is a wireless, wearable Doppler ultrasound device that provides real-time hemodynamic assessments to clinicians. This groundbreaking technology helps healthcare providers make more precise decisions on fluid resuscitation, improving patient outcomes and care efficiency. Flosonics Medical is committed to improving patient care and the practice of medicine through technology-enabled solutions and groundbreaking clinical research.

Flosonics Medical has garnered significant recognition for their innovation. They have secured $20 million in Series C funding led by New Leaf Venture Partners, as well as received the Digital Health Hub Foundation Award as a Rising Star in Clinical Diagnostic Device, Platform or Tool. Flosonics Medical is a growing company with a strong commitment to improving patient care and revolutionizing the way healthcare professionals manage fluids for critically ill patients.

Flosonics Medical is a Canadian medical device company dedicated to improving patient care and the practice of medicine through technology-enabled solutions and ground-breaking clinical research. Their mission is to create cutting-edge technology solutions that support clinicians in providing better treatment, particularly in the area of fluid resuscitation and management.

Flosonics Medical promotes a culture of innovation and collaboration, valuing a team of passionate medical and technological innovators dedicated to improving patient outcomes. They emphasize a patient-centered approach, driven by the mission to create cutting-edge technology solutions that support clinicians in providing better treatment. Their commitment to continuous research and development fosters a dynamic and collaborative environment where individuals can contribute to ground-breaking clinical research and technology-enabled solutions.